Ajanta Pharma Shares Rise to 52-Week High Amid Strong Quarterly Financial Results
Ajanta Pharma's stock has recently reached a 52-week high, gaining about 8% in the past month despite a broader market decline. On Tuesday, its shares rose 2.04% to Rs 3,793.90. The company reported strong financial growth for the quarter ending June 2026, with consolidated revenue increasing to Rs 1,625.96 crore and net profit rising to Rs 334.22 crore, reflecting significant year-on-year improvements. Ajanta Pharma also declared an interim dividend and has a history of bonus issues and stock splits.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (68/100). Lens Score 32/100.
Outlets measured: economictimes, moneycontrol. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (65–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
moneycontrol broke this story on 18 Aug, 06:47 am. Other outlets followed.